The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries

Chest

Volumn 147, Issue 2, 2015, Pages 460-464

  Peljto, Anna L ^a   Selman, Moises ^b   Kim, Dong Soon ^c   Murphy, Elissa ^a   Tucker, Laura ^d   Pardo, Annie ^e   Lee, Jung Su ^c   Ji, Wonjun ^c   Schwarz, Marvin I ^a,f   Yang, Ivana V ^a   Schwartz, David A ^a,f   Fingerlin, Tasha E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c University of Ulsan College of Medicine   (South Korea)

^d YALE UNIVERSITY   (United States)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 5B; TELOMERASE REVERSE TRANSCRIPTASE; MUC5B PROTEIN, HUMAN; SIGNAL PEPTIDE; TOLLIP PROTEIN, HUMAN;

AGED; ALLELE; ARTICLE; ASIAN; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; FAM13A GENE; FEMALE; FIBROSING ALVEOLITIS; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC RISK; HUMAN; IVD GENE; KOREAN (PEOPLE); LRRC34 GENE; MAJOR CLINICAL STUDY; MALE; MEXICAN; MUC5B GENE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TERT GENE; TOLLIP GENE; ASIAN CONTINENTAL ANCESTRY GROUP; CAUCASIAN; ETHNOLOGY; GENETIC VARIABILITY; GENETICS; MEXICO; MIDDLE AGED; SIGNAL TRANSDUCTION; SOUTH KOREA; STATISTICAL MODEL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOGISTIC MODELS; MALE; MEXICO; MIDDLE AGED; MUCIN-5B; REPUBLIC OF KOREA; SIGNAL TRANSDUCTION;

EID: 84928329158     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0867     Document Type: Article

References (17)

1. Fingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifi es multiple susceptibility loci for pulmonary fi brosis. N at Genet. 2013; 45 ( 6): 613-620.
2. Noth I, Zhang Y, Ma SF, et al. Genetic variants associated with idiopathic pulmonary fi brosis susceptibility and mortality: a genome-wide association study. Lancet Respir Med. 2013; 1 ( 4): 309-317.
3. Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fi brosis. N Engl J Med. 2011; 364 ( 16): 1503-1512.
4. Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fi brosis. N Engl J Med. 2007; 356 ( 13): 1317-1326.
5. Tsakiri KD, Cronkhite JT, Kuan PJ, et al. Adult-onset pulmonary fi brosis caused by mutations in telomerase. Proc Natl Acad Sci U SA. 2007; 104 ( 18): 7552-7557.
6. Zhang Y, Noth I, Garcia JG, Kaminski N. A variant in the promoter of MUC5B and idiopathic pulmonary fi brosis. N Engl J Med. 2011; 364 ( 16): 1576-1577.
7. Stock CJ, Sato H, Fonseca C, et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fi brosis but not with development of lung fi brosis in systemic sclerosis or sarcoidosis. Th orax. 2013; 68 ( 5): 436-441.
8. Boucher RC. Idiopathic pulmonary fi brosis-a sticky business. N Engl J Med. 2011; 364 ( 16): 1560-1561.
9. Peljto AL, Zhang Y, Fingerlin TE, et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fi brosis. JAMA. 2013; 309 ( 21): 2232-2239.
10. Hunninghake GM, Hatabu H, Okajima Y, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013; 368 ( 23): 2192-2200.
11. Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An offi cial ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fi brosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183 ( 6): 788-824.
12. Abecasis GR, Auton A, Brooks LD, et al; 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491 ( 7422): 56-65.
13. Altshuler DM, Gibbs RA, Peltonen L, et al; International HapMap 3 Consortium. Integrating common and rare genetic variation in diverse human populations. Nature. 2010; 467 ( 7311): 52-58.
14. Cho MH, Boutaoui N, Klanderman BJ, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet. 2010; 42 ( 3): 200-202.
15. Swigris JJ, Olson AL, Huie TJ, et al. Ethnic and racial differences in the presence of idiopathic pulmonary fi brosis at death. Respir Med. 2012; 106 ( 4): 588-593.
16. Lederer DJ, Arcasoy SM, Barr RG, et al. Racial and ethnic disparities in idiopathic pulmonary fi brosis: A UNOS/OPTN database analysis. Am J Transplant. 2006; 6 ( 10): 2436-2442.
17. Kamio K, Matsushita I, Hijikata M, et al. Promoter analysis and aberrant expression of the MUC5B gene in diff use panbronchiolitis Am J Respir Crit Care Med. 2005; 171 ( 9): 949-957.